Autieri Michael V.
Drug News Perspect. 2002 Oct;15(8):498-505. doi: 10.1358/dnp.2002.15.8.840070.
Allograft inflammatory factor-1 (AIF-1) is a 143-amino acid, cytoplasmic, calcium- binding protein that is expressed in a variety of inflammatory situations. Constitutively expressed in leukocytes, AIF-1 is not expressed in unstimulated vascular smooth muscle cells (VSMCs), but is strongly induced in response to injury and inflammatory cytokines. Overexpression of AIF-1 in VSMCs promotes their proliferation by dysregulation of cell cycle protein expression and subsequent shortening of the cell cycle. In cardiac transplant recipients, the expression of AIF-1 mRNA in cardiac allografts correlates with rejection, and the amount of AIF-1 expressed is proportional to the severity of rejection. AIF-1 is expressed in coronary arteries with cardiac allograft vasculopathy, and persistent expression of AIF-1 in the allograft correlates with development of cardiac allograft vasculopathy. The current hypothesis is that the expression of AIF-1 in injured arteries may participate in the progression of cardiac allograft vasculopathy by its ability to promote growth of VSMCs, implicating AIF-1 as a target for treating proliferative arteriopathies. (c) 2002 Prous Science. All rights reserved.
同种异体移植炎症因子-1(AIF-1)是一种由143个氨基酸组成的细胞质钙结合蛋白,在多种炎症情况下表达。AIF-1在白细胞中组成性表达,在未受刺激的血管平滑肌细胞(VSMC)中不表达,但在受到损伤和炎症细胞因子刺激时会强烈诱导表达。VSMC中AIF-1的过表达通过细胞周期蛋白表达失调和随后细胞周期缩短来促进其增殖。在心脏移植受者中,心脏同种异体移植物中AIF-1 mRNA的表达与排斥反应相关,且AIF-1的表达量与排斥反应的严重程度成正比。AIF-1在患有心脏同种异体移植血管病变的冠状动脉中表达,同种异体移植物中AIF-1的持续表达与心脏同种异体移植血管病变的发展相关。目前的假说认为,AIF-1在受损动脉中的表达可能通过其促进VSMC生长的能力参与心脏同种异体移植血管病变的进展,这表明AIF-1是治疗增殖性动脉病的一个靶点。(c)2002年普劳斯科学出版社。保留所有权利。